Skip to main content
. 2022 Oct 31;13:1029891. doi: 10.3389/fneur.2022.1029891

Table 9.

Clinical studies targeting HMGB1 in depression.

S.N. Type of study Treatment Observations limitation References
Experimental Control
1 Randomized, double-blind, placebo-controlled clinical trial SSRI + GL SSRI + PBO The SSRI + GL group had more relief of depressive symptoms than the SSRI+PBO group The sample size of this study was not large enough and the follow-up time was relatively short (116)